Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;26(1):e142-e152.
doi: 10.1002/onco.13544. Epub 2020 Oct 12.

Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis

Affiliations

Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis

Mary C Politi et al. Oncologist. 2021 Jan.

Abstract

Purpose: We examined self-reported financial toxicity and out-of-pocket expenses among adult women with breast cancer.

Methods: Patients spoke English, Spanish, or Mandarin Chinese, were aged 18+ years, had stage I-IIIA breast cancer, and were eligible for breast-conserving and mastectomy surgery. Participants completed surveys about out-of-pocket costs and financial toxicity at 1 week, 12 weeks, and 1 year postsurgery.

Results: Three hundred ninety-five of 448 eligible patients (88.2%) from the parent trial completed surveys. Excluding those reporting zero costs, crude mean ± SD out-of-pocket costs were $1,512 ± $2,074 at 1 week, $2,609 ± $6,369 at 12 weeks, and $3,308 ± $5,000 at 1 year postsurgery. Controlling for surgery, cancer stage, and demographics with surgeon and clinic as random effects, higher out-of-pocket costs were associated with higher financial toxicity 1 week and 12 weeks postsurgery (p < .001). Lower socioeconomic status (SES) was associated with lower out-of-pocket costs at each time point (p = .002-.013). One week postsurgery, participants with lower SES reported financial toxicity scores 1.02 points higher than participants with higher SES (95% confidence interval [CI], 0.08-1.95). Black and non-White/non-Black participants reported financial toxicity scores 1.91 (95% CI, 0.46-3.37) and 2.55 (95% CI, 1.11-3.99) points higher than White participants. Older (65+ years) participants reported financial toxicity scores 2.58 points lower than younger (<65 years) participants (95% CI, -3.41, -1.74). Younger participants reported significantly higher financial toxicity at each time point.

Discussion: Younger age, non-White race, and lower SES were associated with higher financial toxicity regardless of costs. Out-of-pocket costs increased over time and were positively associated with financial toxicity. Future work should reduce the impact of cancer care costs among vulnerable groups.

Implications for practice: This study was one of the first to examine out-of-pocket costs and financial toxicity up to 1 year after breast cancer surgery. Younger age, Black race, race other than Black or White, and lower socioeconomic status were associated with higher financial toxicity. Findings highlight the importance of addressing patients' financial toxicity in several ways, particularly for groups vulnerable to its effects.

Keywords: Breast cancer; Costs of care; Financial toxicity.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1
Figure 1
Patient flow and data collection. ^, Attempted, unavailable: we reached out to participants a maximum of five times via phone or email (according to patient preference); *, Parent trial concluded: we collected follow‐up data through 6/1/2019, not all participants received surgery within a timeframe that allowed for follow‐up before this date; #, Not attempted: this includes research team turnover, issues with follow‐up reminders, and holidays; +, Ineligible by surgeon review: participant was deemed ineligible after consent based on surgeon review. This was most often the case because their cancer stage changed after additional imaging or the participant no longer had a choice between breast conserving surgery and mastectomy.

Similar articles

Cited by

References

    1. Witte J, Mehlis K, Surmann B et al. Methods for measuring financial toxicity after cancer diagnosis and treatment: A systematic review and its implications. Ann Oncol 2019;30:1061–1070. - PMC - PubMed
    1. Shih YCT, Smieliauskas F, Geynisman DM et al. Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol 2015;33:2190–2196. - PMC - PubMed
    1. Azzani M, Roslani AC, Su TT. The perceived cancer‐related financial hardship among patients and their families: A systematic review. Support Care Cancer 2015;23:889–898. - PubMed
    1. Bestvina CM, Zullig LL, Rushing C et al. Patient‐oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 2014;10:162–167. - PMC - PubMed
    1. McGuire A, Drummond M, Martin M et al. End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes? Expert Rev Pharmacoecon Outcomes Res 2015;15:599–605. - PubMed

Publication types